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Abstract
Sepsis-associated encephalopathy is associated with increased mortality and morbidity. Its pathophysiology remains
insufficiently elucidated, although there is evidence for a neuroinflammatory process sequentially involving
endothelial activation, blood-brain barrier alteration and cellular dysfunction and alteration in neurotransmission.
Experimental studies have shown that microcirculatory dysfunction, a consequence of endothelial activation, is an
early pathogenic step. To date, we do not know whether it is present in septic patients, whether it accounts for
clinical features and whether it is treatable.
The experimental study by Taccone and colleagues
recently published in Critical Care [1] aims to deter-
mine whether sepsis is associated with early cerebral
micro-circulatory failure, which is believed to play a role
in the pathophysiology of sepsis-associated encephalopa-
thy (SAE). SAE is a frequent and severe complication of
sepsis as it is associated with increased mortality, mor-
bidity and plausibly with diminished long-term cognitive
performance [2,3]. Evidence suggests that SAE results
from an alteration of neurotransmission, the mechan-
isms of which are insufficiently elucidated.
One pathophysiologic scenario is an inflammatory
process that starts by cerebral endothelial activation [3],
which directly releases or, through alteration of the
blood-brain barrier, facilitates the passage of inflamma-
tory mediators (that is, cytokines, chemokines) into the
parenchyma. Increased permeability of the blood-brain
barrier has been extensively documented in experimen-
tal models of sepsis, has been linked to complement
activation [4], and has been observed in septic patients
using magnetic resonance imaging (MRI) [5]. In turn,
these inflammatory mediators will affect all brain cells.
Van Gool and colleagues [6] proposed that sepsis-
induced microglial activation plays a role in delirium.
Inflammatory mediators are able to alter cellular meta-
bolism by inducing oxidative stress and mitochondrial
dysfunction [7], resulting in pathologic abnormalities
that range from alterations of neurotransmission to
apoptosis [8]. It has been shown that experimental sep-
sis, via inflammatory mediators, alters brain cholinergic
[9], beta-adrenergic, gamma-aminobutyric acid and sero-
toninergic signalling, predominately in the neocortex
and hippocampus [10]. This feature may account for the
electroencephalographic disturbances reported in septic
patients [11]. Additional factors that compound this
neuroinflammatory process include the release of excita-
tory amino acids, hyperglycemia, exposure to neurotoxic
pharmacologic agents, hemodynamic alterations, coagu-
lopathy, and hypoxemia [3].
One major consequence of endothelial activation is
that it may compromise regional brain tissue perfusion
by altering microcirculation. Microcirculatory dysfunc-
tion (MD) has previously been experimentally assessed,
notably by measuring neurovascular coupling. This con-
sists of assessing changes in cortical flow velocity during
somatosensory activation [12]. Interestingly, this MD
preceded both neurophysiologic and macrocirculatory
alterations, indicating that it is an early step in the
pathogenesis of SAE. Taccone and colleagues [1] pro-
vide a convincing visual demonstration of this phenom-
enon. Using cortical videomicroscopy in an ovine
peritonitis model, they found evidence of a reduced den-
sity of perfused and functional capillaries. But if the
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lished, it remains to be seen whether this phenomenon
is present in septic patients, whether it accounts for
clinical features of SAE and whether it is treatable. The
microcirculation has not been evaluated in septic
patients; in contrast, several studies have examined
macrocirculatory changes with inconsistent results [3].
One argument may be the impairment of autoregulation
reported in some studies of septic patients [13],
although autoregulation is primarily determined by
arterioles, which lie outside micro-circulation. Neuro-
pathologic findings of diffuse ischemic damages and
micro-haemorrhages support this hypothesis [14].
Recent advances in MRI are enabling important infer-
ences regarding the cerebral microcirculation; however,
simpler techniques are needed to directly assess and
monitor cerebral microcirculation or correlated markers
at the bedside. It would be of interest to determine
whether cerebral MD is correlated with micro-circula-
tory disturbances in other organs that are more easily
amenable to direct assessment. The neurological conse-
quence of MD is unknown, although one study interest-
ingly showed that delirium in septic patients is
associated with disturbed autoregulation rather than
with altered cerebral blood flow or tissue oxygenation
[13].
The clinical importance of cerebral microcirculatory
impairment in sepsis might be confirmed by assessing
the effects of therapeutic intervention. Prominent
micro-circulatory effects of various agents have been
tested in septic animals, including curcumin, bradykinin,
inducible nitric oxide synthase (iNOS) inhibitors, anti-
cytokines or complement antibodies and glucocorticoids
[15]. The effects of glucocorticoids and that of other
therapeutic agents used in sepsis (that is, activated pro-
tein C) on SAE are unknown. One other major unan-
swered issue is whether targeting higher systemic blood
pressures will improve cerebral perfusion and oxygena-
tion in the presence of MD.
O n em a ya r g u et h a tM Di sm e r e l yo n ef e a t u r ei nt h e
complex pathogenesis of SAE. In the experimental set-
ting it will be important to develop agents or strategies
that modulate what ostensibly is an early pathogenic
phenomenon rather than targeting later events that may
not be reversible. In patients, we need more evidence of
the role of microcirculation in SAE. This will require
techniques to measure and monitor the cerebral micro-
circulation at the bedside.
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